Associations Between Nutritional Status, Sleep Quality, and Clinical Factors in Patients With Metastatic Prostate Cancer

ArticleAçık Erişim

Özet

PURPOSE – Malnutrition and poor sleep quality are common but underrecognized issues among patients with metastatic prostate cancer (mPC). This study aimed to examine the associations between nutritional status, sleep quality, and clinical outcomes in men with mPC. METHODS – In this cross-sectional study, 91 men with stage IV prostate cancer were evaluated for nutritional status using the Subjective Global Assessment (SGA) and sleep quality using the Pittsburgh Sleep Quality Index (PSQI). Clinical and laboratory parameters, including albumin, hemoglobin, C-reactive protein (CRP), and quality-of-life scores (EORTC QLQ-C30 and QLQ-PR25), were compared across SGA categories and sleep quality groups. Multivariable logistic regression was used to identify predictors of poor sleep (PSQI >5).RESULTS – Overall, 60.4% of patients were castration-resistant, and 38.5% were severely malnourished (SGA C). Poor sleep quality was observed in 65.9% of patients and was significantly more prevalent among those with moderate-to-severe malnutrition (P < .001). Patients with worse nutritional status exhibited lower albumin and hemoglobin levels, higher CRP, poorer performance status, and worse quality-of-life scores across all domains (P < .001). In multivariable analysis, independent predictors of poor sleep included higher CRP (odds ratio [OR], 1.33 [95% CI, 1.11 to 1.61), lower hemoglobin (OR, 0.66 [95% CI, 0.46 to 0.93]), and poorer nutritional status (SGA C v A, OR, 5.06 [95% CI, 1.70 to 15.05]).CONCLUSION – Malnutrition and systemic inflammation are closely linked with impaired sleep quality and diminished quality of life in mPC. Nutritional screening and targeted interventions may represent an important component of supportive care for optimizing well-being in this population. © 2026 American Society of Clinical Oncology

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10410Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1200/op-25-01174Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAkagunduz, Digdem Dogan
dc.contributor.authorSahin, Hilal
dc.contributor.authorHendem, Engin
dc.contributor.authorAkagunduz, Baran
dc.date.accessioned2026-10-18T20:25:37.836046994Z
dc.date.available2026-10-18T20:25:37.836046994Z
dc.date.issued2026
dc.description.abstractPURPOSE – Malnutrition and poor sleep quality are common but underrecognized issues among patients with metastatic prostate cancer (mPC). This study aimed to examine the associations between nutritional status, sleep quality, and clinical outcomes in men with mPC. METHODS – In this cross-sectional study, 91 men with stage IV prostate cancer were evaluated for nutritional status using the Subjective Global Assessment (SGA) and sleep quality using the Pittsburgh Sleep Quality Index (PSQI). Clinical and laboratory parameters, including albumin, hemoglobin, C-reactive protein (CRP), and quality-of-life scores (EORTC QLQ-C30 and QLQ-PR25), were compared across SGA categories and sleep quality groups. Multivariable logistic regression was used to identify predictors of poor sleep (PSQI >5).RESULTS – Overall, 60.4% of patients were castration-resistant, and 38.5% were severely malnourished (SGA C). Poor sleep quality was observed in 65.9% of patients and was significantly more prevalent among those with moderate-to-severe malnutrition (P < .001). Patients with worse nutritional status exhibited lower albumin and hemoglobin levels, higher CRP, poorer performance status, and worse quality-of-life scores across all domains (P < .001). In multivariable analysis, independent predictors of poor sleep included higher CRP (odds ratio [OR], 1.33 [95% CI, 1.11 to 1.61), lower hemoglobin (OR, 0.66 [95% CI, 0.46 to 0.93]), and poorer nutritional status (SGA C v A, OR, 5.06 [95% CI, 1.70 to 15.05]).CONCLUSION – Malnutrition and systemic inflammation are closely linked with impaired sleep quality and diminished quality of life in mPC. Nutritional screening and targeted interventions may represent an important component of supportive care for optimizing well-being in this population. © 2026 American Society of Clinical Oncology
dc.identifier.doi10.1200/op-25-01174
dc.identifier.eissn2688-1535
dc.identifier.issn2688-1527
dc.identifier.pmid41707117
dc.identifier.scopus2-s2.0-105035847112
dc.identifier.startpageOP-25-01174
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10410
dc.identifier.volume8
dc.identifier.wosWOS:001820942400001
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofJCO Oncology Practice
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectalbumin
dc.subjectC reactive protein
dc.subjecthemoglobin
dc.subjectaged
dc.subjectalbumin blood level
dc.subjectArticle
dc.subjectcancer patient
dc.subjectcancer staging
dc.subjectcastration resistant prostate cancer
dc.subjectclinical feature
dc.subjectclinical outcome
dc.subjectcontrolled study
dc.subjectcross-sectional study
dc.subjectdisease association
dc.subjectdisease severity
dc.subjectEuropean Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
dc.subjecthemoglobin blood level
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmalnutrition
dc.subjectmen's health
dc.subjectmetastatic prostate cancer
dc.subjectnutritional assessment
dc.subjectnutritional status
dc.subjectobservational study
dc.subjectPittsburgh Sleep Quality Index
dc.subjectprotein blood level
dc.subjectQLQ PR25
dc.subjectquality of life
dc.titleAssociations Between Nutritional Status, Sleep Quality, and Clinical Factors in Patients With Metastatic Prostate Cancer
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.wos1
rdl.departmentDepartment of Nutrition and Dietetics, Erzincan Binali Yildirim University Mengücek Gazi Training and Research Hospital, Erzincan, Turkey. | Department of Nutrition and Dietetics, Faculty of Health Science, Binali Yildirim University, Erzincan, Turkey. | Department of Medical Oncology, Erzincan Binali Yildirim University Medical School, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)